Dr. Raza Bokhari and RBx Capital, LP filed Amendment No. 1 to Schedule 13D with the SEC on November 17, 2026, disclosing a private placement purchase of 436,046 common shares of Medicus Pharma Ltd. on November 13, 2026.
Key Highlights
- Private placement transaction: RBx Capital, LP purchased 436,046 common shares of Medicus Pharma Ltd. at $1.72 per share on November 13, 2026.
- Aggregate purchase price: The total consideration paid was $749,999.12, funded by the working capital of RBx Capital, LP.
- Combined beneficial ownership: Dr. Raza Bokhari now beneficially owns 538,233 common shares in aggregate, representing 19.1% of the class.
- RBx Capital stake: RBx Capital, LP holds 451,909 common shares, representing 16.2% of the class.
- Shares outstanding: Percentages are based on 2,788,106 common shares issued and outstanding as of November 16, 2026, as confirmed by the Issuer's transfer agent.
- Purpose stated: According to the filing, RBx Capital, LP acquired the shares "for general investment purposes."
RBx Capital Private Placement and Bokhari Ownership in Medicus Pharma
According to the filing, this Amendment No. 1 supplements the original Schedule 13D filed with the SEC on September 14, 2026. The triggering event was a subscription agreement entered into on November 13, 2026, under which RBx Capital, LP agreed to purchase 436,046 common shares in a private placement by Medicus Pharma Ltd. at a purchase price of $1.72 per common share, for an aggregate purchase price of $749,999.12. The filing states that these shares were acquired using the working capital of RBx Capital, LP.
Dr. Raza Bokhari is identified as the controlling person of RBx Capital, LP and serves as its Managing Partner. The filing notes that Dr. Bokhari's aggregate beneficial ownership of 538,233 shares comprises three components: 58,924 common shares held directly by Dr. Bokhari, 27,500 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days, and 451,909 common shares held by RBx Capital, LP. The filing states that "Dr. Raza Bokhari disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."
The filing reports sole voting and dispositive power of 86,424 shares for Dr. Bokhari, with shared voting and dispositive power of 451,909 shares, reflecting his control over RBx Capital, LP. The filing states that, aside from the described private placement, neither reporting person effected any other transaction in the common shares during the 60 days preceding the November 13, 2026 event date.
What Was Disclosed
The filing disclosed a private placement in which RBx Capital, LP purchased 436,046 Medicus Pharma common shares at $1.72 each for $749,999.12 on November 13, 2026, raising Dr. Raza Bokhari's aggregate beneficial ownership to 538,233 shares, or 19.1% of the class.




Please wait processing your request...